
AI-generated summary
The built-in health monitoring function of smart watches has become popular, but its accuracy and clinical benefits have attracted attention from the medical community.
Smart watches have become a part of many people's lives, and the various built-in health monitoring functions have become users' "personal doctors." Many people wear them throughout the day to keep an eye on their physical condition. However, the latest international research warns that the "atrial fibrillation detection" function of smart watches may lead to a high rate of "misdiagnosis," causing people to suffer from increased anxiety or unnecessary medical expenses.
According to Korean media reports, a multi-national research team from the United States and Europe analyzed the atrial fibrillation (AFib) detection functions of smart watches such as Apple and Samsung and found that although smart watches can assist in early detection, international journal studies show that in daily life, the proportion of "misdiagnoses" issued by watches will increase significantly.
A joint Danish-Norwegian study published in the Scandinavian Journal of Primary Health Care in 2026 found that although continuous monitoring with wearable devices tripled the diagnosis rate of atrial fibrillation and tripled the prescription rate of anticoagulant drugs, the effect on reducing health risks such as stroke or death was quite weak.
The research team estimated that the proportion of "over-medical treatment" (unhelpful treatment due to minor symptoms that do not pose a threat to health) caused by wearing smart watches is between 8% and 29%. If only cases without physical abnormalities are counted, as many as 47% to 65% of users seek medical treatment due to "misdiagnosis." Experts remind that smart watch alarms can be used as a health reference, but there is no need to panic too much. If people have no relevant symptoms and blindly rely on daily wearable device monitoring, they may fall into the dilemma of ineffective diagnosis and excessive medical treatment.

The Ministry of Health and Welfare has launched the Dementia Care 3.0 Plan, with the goal of achieving "Dementia Friendly Taiwan 888" by 2035, that is, the diagnosis rate, service coverage rate, and specific field literacy rate will all reach 80%. The service targets are expanded to all age groups, and employment support and family care resources for young people with dementia are strengthened.

Forest and land fires in Indonesia have affected 63 counties and cities in 7 provinces, resulting in more than 277,000 cases of acute respiratory infection. The Indonesian Ministry of Health has deployed 2,106 medical personnel and distributed 3 million masks and medical supplies to the disaster-stricken areas, focusing on protecting the health of vulnerable groups such as infants and young children.

In response to the influenza epidemic, the Pingtung County Health Bureau will simultaneously provide night-time influenza and COVID-19 vaccination services for infants and young children at 33 township and municipal health centers on two consecutive Fridays, October 16 and October 23, so that parents can take their children and elders to get vaccinated after get off work.

The Executive Yuan passed the "Dementia Prevention and Care Policy Framework and Action Plan 3.0" on the 15th, aiming to achieve "Dementia Friendly Taiwan 888" by 2035, covering accurate diagnosis, service coverage and literacy rate reaching 80%, and for the first time including young people with dementia under the age of 50.

The National Health Administration of the Ministry of Health and Welfare has promoted the pilot program of medical fertility preservation subsidy for one year, and a total of 215 cancer patients have passed it. The Taiwan Egg Freezing Association and doctors called for subsidies to be assessed based on "the degree of damage to fertility" and should not be limited to specific cancer types. The National Health Administration stated that the long-term impact on fertility is a possible direction of relaxation in the future, and there is no clear timetable.

Four departments including the State Administration for Market Regulation announced the results of a joint investigation into the formamide problem in infant diapers. After random inspections, re-inspections and expert demonstrations, formamide was not detected in 368 batches of finished diapers and 210 blood samples. Public opinion reflected that the relevant testing was not rigorous in many aspects.